1. Home
  2. SFL vs EVO Comparison

SFL vs EVO Comparison

Compare SFL & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFL
  • EVO
  • Stock Information
  • Founded
  • SFL 2003
  • EVO 1993
  • Country
  • SFL Bermuda
  • EVO Germany
  • Employees
  • SFL N/A
  • EVO N/A
  • Industry
  • SFL Marine Transportation
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFL Consumer Discretionary
  • EVO Health Care
  • Exchange
  • SFL Nasdaq
  • EVO Nasdaq
  • Market Cap
  • SFL 1.5B
  • EVO 1.5B
  • IPO Year
  • SFL N/A
  • EVO 2021
  • Fundamental
  • Price
  • SFL $10.89
  • EVO $4.64
  • Analyst Decision
  • SFL Strong Buy
  • EVO Buy
  • Analyst Count
  • SFL 2
  • EVO 2
  • Target Price
  • SFL $14.50
  • EVO $5.90
  • AVG Volume (30 Days)
  • SFL 777.5K
  • EVO 53.2K
  • Earning Date
  • SFL 02-28-2025
  • EVO 11-06-2024
  • Dividend Yield
  • SFL 9.93%
  • EVO N/A
  • EPS Growth
  • SFL 39.68
  • EVO N/A
  • EPS
  • SFL 1.10
  • EVO N/A
  • Revenue
  • SFL $876,068,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • SFL $21.02
  • EVO $3.89
  • Revenue Next Year
  • SFL N/A
  • EVO $10.89
  • P/E Ratio
  • SFL $9.60
  • EVO N/A
  • Revenue Growth
  • SFL 19.50
  • EVO N/A
  • 52 Week Low
  • SFL $9.64
  • EVO $2.85
  • 52 Week High
  • SFL $14.62
  • EVO $7.98
  • Technical
  • Relative Strength Index (RSI)
  • SFL 50.06
  • EVO 58.49
  • Support Level
  • SFL $10.32
  • EVO $4.24
  • Resistance Level
  • SFL $10.79
  • EVO $4.54
  • Average True Range (ATR)
  • SFL 0.24
  • EVO 0.10
  • MACD
  • SFL -0.02
  • EVO 0.05
  • Stochastic Oscillator
  • SFL 26.22
  • EVO 100.00

About SFL SFL Corporation Ltd

SFL Corp Ltd is an international ship owning and chartering company. The company is engaged primarily in the ownership and operation of vessels and offshore related assets and is also involved in the charter, purchase, and sale of assets. Its oil tankers, chemical tankers, and oil product tankers are all double-hull vessels.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: